Global Pharma Manufacturing in Flux: Adapting to a New Era of Complexity

Pharmaceutical manufacturing is undergoing a profound transformation. Geopolitical volatility, rising demand for specialised therapies, inflationary pressures, and shifting regulatory expectations are reshaping how and where medicines are made. In this keynote, we’ll explore the evolving market dynamics that CDMOs and pharma companies must navigate, from regionalisation of supply chains and capital investment constraints to the rising need for strategic, flexible partnerships. This session will provide a high-level snapshot of the global manufacturing environment and outline what’s needed to compete – and thrive – in this next chapter of the industry.